Orthoclone OKT3 and cyclosporine are two types of immunosuppressive agents that do not affect the entire immune system when given to prevent and treat allograft rejection

Indicate whether the statement is true or false.

ANS: T
The drug cyclosporine reduces rejection, especially in the early or inductive phase, without suppressing the entire immune system. Monoclonal antilymphocyte globulin, muromonab-CD3 (Orthoclone OKT3), is derived from mouse antibodies and is used for the successful treatment of established allograft rejection without affecting the entire immune system.